Published in Cancer on June 15, 1991
Implication of cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res (1995) 1.68
In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase. Cancer Chemother Pharmacol (2012) 0.85
Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures. BMC Cancer (2006) 0.84
Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions. Am J Pathol (1995) 0.82
The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer. Clinics (Sao Paulo) (2013) 0.78
PRE-CLINICAL AND CLINICAL VALIDATION OF AN ANTI-CANCER MODALITY THAT ABLATES REFRACTORY, LOW GROWTH FRACTION TUMORS. Trans Am Clin Climatol Assoc (2016) 0.75
The role of the nuclear matrix in the organization and function of DNA. Annu Rev Biophys Biophys Chem (1986) 2.07
The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues. J Biol Chem (1980) 1.66
Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer (1991) 1.39
Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A (1992) 1.28
Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy. Cancer (1993) 1.24
The relationship of the nuclear matrix to cellular structure and function. Adv Enzyme Regul (1978) 1.23
Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol (1992) 1.21
Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res (1997) 1.14
Estrogen receptors in human prostate: evidence for multiple binding sites. J Clin Endocrinol Metab (1983) 1.14
The nuclear matrix of the prostate contains acceptor sites for androgen receptors. Endocrinology (1983) 1.05
Concepts related to salt resistant estradiol receptors in rat uterine nuclei: nuclear matrix. Biochem Biophys Res Commun (1977) 0.95
Expression of transforming growth factor-beta 1 in prostate cancer. Endocrinology (1994) 0.95
Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res (1995) 0.92
Androgen-receptor gene structure and function in prostate cancer. World J Urol (1996) 0.90
The regulation of nuclear DNA template restrictions by acidic polymers. Adv Enzyme Regul (1974) 0.90
Biological properties of the nuclear matrix: steroid hormone binding. Recent Prog Horm Res (1982) 0.89
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun (1994) 0.86
Immunogold probes for electron microscopy: evaluation of staining by fluorescence microscopy. J Histochem Cytochem (1985) 0.86
Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors. Cancer Res (1983) 0.85
Sexually dimorphic expression of estrogen receptors, but not of androgen receptors in human fetal external genitalia. J Clin Endocrinol Metab (1993) 0.84
The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines. J Urol (1984) 0.84
Androgen receptors and growth fraction in metastatic prostate cancer as predictors of time to tumour progression after hormonal therapy. Cancer Surv (1991) 0.80
Simultaneous measurement of progesterone and androgen receptors in human prostate: a microassay. J Clin Endocrinol Metab (1982) 0.80
Estrogen receptors in the nuclear matrix: direct demonstration using monoclonal antireceptor antibody. Endocrinology (1987) 0.80
Mitogenesis in normal human fibroblasts by polyinosinic . polycytidylic acid and other synthetic acidic polymers: enhancement of action by glucocorticoids. J Cell Physiol (1981) 0.80
Immunocytochemical localization of estrogen receptors in the normal male and female canine urinary tract and prostate. Endocrinology (1987) 0.79
Affinity chromatography of steroid-transforming enzymes. Methods Enzymol (1974) 0.78
The relationship of cellular structure and function: the matrix system. Prog Clin Biol Res (1981) 0.78
DNA synthesis in the canine prostate: effects of androgen and estrogen treatment. Prostate (1987) 0.77
Androgen receptor localization in the human prostate: demonstration of heterogeneity using a new method of steroid receptor autoradiography. J Steroid Biochem (1987) 0.77
Effects of transforming growth factor beta 1 on the adenylyl cyclase-cAMP pathway in prostate cancer. Growth Factors (1994) 0.76
The specific binding of estradiol to the nuclear matrix. Adv Exp Med Biol (1979) 0.75
A new method for labeling and autoradiographic localization of androgen receptors. J Histochem Cytochem (1987) 0.75
Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia. Prostate (1987) 0.75